Walleye Trading
CRDF icon

Walleye Trading’s Cardiff Oncology CRDF Stock Holding History

Walleye Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,154
Closed -$75.6K – 5201
2022
Q1 		$112K Buy
45,154
+28,856
+177% +$102K ﹤0.01% 4179
2021
Q4 		$98K Buy
+16,298
New +$97.1K ﹤0.01% 4385
2015
Q3 		– Sell
-4
Closed -$3K – 5027
2015
Q2 		$3K Buy
+4
New +$2.84K ﹤0.01% 4605

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Walleye Trading's CRDF Position: Q2 2022 in Review

Walleye Trading sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 45,154 shares — an estimated $75.6K sold.

Walleye Trading first reported a position in CRDF in Q2 2015 and held it in 3 quarters. The position peaked at $112K in Q1 2022. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Walleye Trading reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 45,154 Cardiff Oncology shares in Q2 2022, an estimated $75.6K.
  • Walleye Trading first reported a position in Cardiff Oncology in Q2 2015 and held it in 3 quarters.
  • Walleye Trading's Cardiff Oncology position peaked at $112K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.